Upadacitinib Effective for Rare Disorder in Case Series

A high dose of upadacitinib resulted in a meaningful clinical response in a study of several patients with long-standing recalcitrant granulomatous cheilitis.
Medscape Medical News

source https://www.medscape.com/viewarticle/upadacitinib-effective-rare-granulomatous-disorder-case-2024a1000e83?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost